ML

Myla Lai-Goldman

North America, Vermont, United States, South Burlington

Description

Myla Lai-Goldman is a Co-Founder and Chair at GeneCentric Therapeutics and a Venture Partner at Hatteras Venture Partners. Myla was an Execu...

Investor Profile

Myla Lai-Goldman has made 1 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Seed (100%)

Country Focus

  • United States (100%)

Industry Focus

  • Artificial Intelligence (Ai)
  • Health Care
  • Machine Learning
  • Medical Device
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Myla Lai-Goldman frequently co-invest with?

Inflect Health
North America, California, United States, Emeryville
Co-Investments: 1
Y Combinator
North America, California, United States, Mountain View
Co-Investments: 1
Promus Ventures
North America, Illinois, United States, Chicago
Co-Investments: 1
1984 Ventures
North America, California, United States, San Francisco
Co-Investments: 1
Hula
North America, Vermont, United States, Burlington
Co-Investments: 1
Breyer Capital
North America, California, United States, Menlo Park
Co-Investments: 1

Which angels does Myla Lai-Goldman often collaborate with?

JH
North America, California, United States, San Francisco
Shared Deals: 1
JA
North America, Massachusetts, United States, Marlborough
Shared Deals: 1
LG
North America, New York, United States, New York
Shared Deals: 1
SP
North America, Connecticut, United States, Southport
Shared Deals: 1

What are some of recent deals done by Myla Lai-Goldman?

Biocogniv

Burlington, Vermont, United States

Upgrade your clinical operations with real-time AI

Artificial Intelligence (AI)Health CareMachine LearningMedical Device
SeedAug 31, 2020
Amount Raised: $6,000,000